ReTo Eco-Solutions Subsidiary Showcases Equipment and Intelligent Solutions at Excon 2025 to Advance India Market Presence
BEIJING, Dec. 12, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company") today announced that its wholly owned subsidiary, Beijing REIT Equipment Technology Co., Ltd. ("REIT Equipment"), is participating in Excon...
Youlife Group Inc. Announces Non-Binding Letter of Intent as It explores Strategic Expansion in China's Blue-Collar Service Market
BEIJING, Dec. 12, 2025 /PRNewswire/ -- Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has entered into a non-binding letter of intent (the "LOI"),...
12TH ANNUAL WINTERNATIONAL EMBASSY SHOWCASE DRAWS 8,000 GUESTS
70 Embassies Unite to Celebrate Global Culture and Traditions at the Ronald Reagan Building and International Trade Center in Washington, DC WASHINGTON, Dec. 12, 2025 /PRNewswire/ -- On Tuesday, December 9, 2025, the 12th Annual Embassy Showcase,...
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy
NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18...
Holiday Demand Marks Monport's Mission to Support Expanding Craft on Custom Laser Engraving
NEW YORK, Dec. 12, 2025 /PRNewswire/ -- The holiday season has sparked renewed interest in the tools behind today's personalization boom, with many creators seeking reliable CO2 laser cutter engraver and fiber laser engraving systems to meet rising...
Beijing Review: Harmony over hubris
BEIJING, Dec. 12, 2025 /PRNewswire/ -- Humanity finds itself today at a nodal point in world history, as German philosopher G.W.F. Hegel would call it. We are in the earliest stages of a leap that will mark an era for history books in the future. A...
Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD)
Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD inhibitor with IND clearance granted in 2023. The...
The New Essential: Comfee Gusto Delivers Value and 'Worry-Free' Comfort to Young Malaysians
KUALA LUMPUR, Malaysia, Dec. 12, 2025 /PRNewswire/ -- Young consumers in Malaysia face increasing pressure regarding housing, whether setting up a new home or replacing appliances in an existing one. They need modern, high-quality, and...